Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our disclosure dated May 06, 2023 with respect to Schedule of Analysts and Investors Earnings Call to discuss the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and financial year ended March 31, 2023, please find attached herewith the presentation made at the Investors/ Analysts Earning call.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our disclosure dated January 27, 2022, with respect to Schedule of Analysts and Investors Earnings Call to discuss the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months' period ended on December 31, 2022, please find attached herewith the presentation made at the Investors/ Analysts Earning call.
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Meeting with investors / analysts and investment funds / organisations.
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Meeting with investors / analysts and investment funds / organisations.
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Meeting with investors / analysts and investment funds / organisations.
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Meeting with investors / analysts and investment funds / organisations.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our disclosures dated November 01, 2022, and November 03, 2022, please find enclosed the Transcript of the Earnings call held on November 03, 2022, with the Analysts / Investors.
